Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Triptorelin|DRUG: Exemestane|DRUG: Nivolumab
Sponsor: Istituto Oncologico Veneto IRCCS
Collaborators: University of Padova